PLASMIC score for estimating the risk of ADAMPTS13 deficiency: Difference between revisions

Revision as of 15:55, 23 August 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]

Risk of ADAMPTS13 deficiency in adults with suspected TTP:

@@ Line 4: / Line 4: @@
 {{#Widget:PLASMIC score}}
 <br>
-'''<big>Risk of ADAMPTS13 deficiency</big>''' <ref name="JammeRondeau2017">{{cite journal|last1=Jamme|first1=Matthieu|last2=Rondeau|first2=Eric|title=The PLASMIC score for thrombotic thrombocytopenic purpura|journal=The Lancet Haematology|volume=4|issue=4|year=2017|pages=e148–e149|issn=23523026|doi=10.1016/S2352-3026(17)30024-8}}</ref>'''<big>:</big>'''
+'''<big>Risk of ADAMPTS13 deficiency</big>'''  '''<big>in adults with suspected TTP:</big>'''
+* '''Low-risk''' = 0 to 4 points
-'''Low-risk''' = 0 to 4 points
+* '''Intermediate risk''' = 5 points
+* '''High-risk''' = 6 to 7 points
-'''Intermediate risk''' = 5 points
+==References==
+<references />
-'''High-risk''' = 6 to 7 points

Platelet count (< 30,000/microL)
Hemolysis variables (Retic count > 2.5%, undetectable haptoglobin, indirect billi <2 mg/dL( >34 mcmol/L))
Absence of active cancer
Absence of transplant history (solid, stem cell)
MCV < 90 Fl
INR < 1.5
Serum creatinine < 2 mg/dL (<177 mcmol/L)